Annual Net Income
-$102.24 M
+$7.54 M+6.87%
31 December 2023
Summary:
UroGen Pharma annual net profit is currently -$102.24 million, with the most recent change of +$7.54 million (+6.87%) on 31 December 2023. During the last 3 years, it has risen by +$26.24 million (+20.42%). URGN annual net income is now -5167.59% below its all-time high of -$1.94 million, reached on 31 December 2016.URGN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$23.67 M
+$9.73 M+29.13%
30 September 2024
Summary:
UroGen Pharma quarterly net profit is currently -$23.67 million, with the most recent change of +$9.73 million (+29.13%) on 30 September 2024. Over the past year, it has dropped by -$1.79 million (-8.20%). URGN quarterly net income is now -283.19% below its all-time high of $12.92 million, reached on 31 December 2016.URGN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$115.38 M
-$1.79 M-1.58%
30 September 2024
Summary:
UroGen Pharma TTM net profit is currently -$115.38 million, with the most recent change of -$1.79 million (-1.58%) on 30 September 2024. Over the past year, it has dropped by -$10.28 million (-9.78%). URGN TTM net income is now -3934.43% below its all-time high of $3.01 million, reached on 30 September 2017.URGN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.9% | -8.2% | -9.8% |
| 3 y3 years | +20.4% | +21.6% | -2.2% |
| 5 y5 years | -35.1% | -6.4% | -28.4% |
URGN Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +20.4% | -8.2% | +29.1% | -12.8% | at low |
| 5 y | 5 years | -35.1% | +20.4% | -8.2% | +39.3% | -28.4% | +15.7% |
| alltime | all time | -5167.6% | +20.4% | -283.2% | +39.3% | -3934.4% | +15.7% |
UroGen Pharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.67 M(-29.1%) | -$115.38 M(+1.6%) |
| June 2024 | - | -$33.40 M(+3.5%) | -$113.58 M(+8.9%) |
| Mar 2024 | - | -$32.29 M(+24.1%) | -$104.32 M(+2.0%) |
| Dec 2023 | -$102.24 M(-6.9%) | -$26.02 M(+18.9%) | -$102.24 M(-2.7%) |
| Sept 2023 | - | -$21.88 M(-9.4%) | -$105.10 M(-3.6%) |
| June 2023 | - | -$24.14 M(-20.1%) | -$109.05 M(-2.3%) |
| Mar 2023 | - | -$30.21 M(+4.7%) | -$111.60 M(+1.7%) |
| Dec 2022 | -$109.78 M(-0.9%) | -$28.87 M(+11.8%) | -$109.78 M(+0.4%) |
| Sept 2022 | - | -$25.83 M(-3.2%) | -$109.37 M(-3.9%) |
| June 2022 | - | -$26.69 M(-6.0%) | -$113.75 M(+0.4%) |
| Mar 2022 | - | -$28.39 M(-0.2%) | -$113.28 M(+2.2%) |
| Dec 2021 | -$110.82 M(-13.7%) | -$28.45 M(-5.8%) | -$110.82 M(-1.8%) |
| Sept 2021 | - | -$30.21 M(+15.2%) | -$112.89 M(+1.3%) |
| June 2021 | - | -$26.22 M(+1.1%) | -$111.50 M(-4.4%) |
| Mar 2021 | - | -$25.93 M(-15.0%) | -$116.63 M(-9.2%) |
| Dec 2020 | -$128.48 M | -$30.53 M(+5.9%) | -$128.48 M(-6.2%) |
| Sept 2020 | - | -$28.82 M(-8.1%) | -$136.93 M(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$31.35 M(-17.1%) | -$130.37 M(+7.3%) |
| Mar 2020 | - | -$37.79 M(-3.0%) | -$121.50 M(+15.5%) |
| Dec 2019 | -$105.15 M(+39.0%) | -$38.97 M(+75.1%) | -$105.15 M(+17.0%) |
| Sept 2019 | - | -$22.25 M(-1.0%) | -$89.89 M(+1.9%) |
| June 2019 | - | -$22.48 M(+4.8%) | -$88.17 M(+5.3%) |
| Mar 2019 | - | -$21.44 M(-9.6%) | -$83.72 M(+10.7%) |
| Dec 2018 | -$75.66 M(+278.3%) | -$23.72 M(+15.5%) | -$75.66 M(+22.0%) |
| Sept 2018 | - | -$20.53 M(+13.9%) | -$62.03 M(+48.4%) |
| June 2018 | - | -$18.03 M(+34.7%) | -$41.79 M(+39.5%) |
| Mar 2018 | - | -$13.38 M(+32.7%) | -$29.96 M(+49.8%) |
| Dec 2017 | -$20.00 M(+930.4%) | -$10.09 M(+3284.6%) | -$20.00 M(-764.7%) |
| Sept 2017 | - | -$298.00 K(-95.2%) | $3.01 M(-164.3%) |
| June 2017 | - | -$6.20 M(+81.4%) | -$4.68 M(+160.3%) |
| Mar 2017 | - | -$3.42 M(-126.4%) | -$1.80 M(-211.1%) |
| Dec 2016 | -$1.94 M(-84.7%) | $12.92 M(-261.8%) | $1.62 M(-114.3%) |
| Sept 2016 | - | -$7.99 M(+140.8%) | -$11.30 M(+240.8%) |
| June 2016 | - | -$3.32 M | -$3.32 M |
| Dec 2015 | -$12.69 M | - | - |
FAQ
- What is UroGen Pharma annual net profit?
- What is the all time high annual net income for UroGen Pharma?
- What is UroGen Pharma annual net income year-on-year change?
- What is UroGen Pharma quarterly net profit?
- What is the all time high quarterly net income for UroGen Pharma?
- What is UroGen Pharma quarterly net income year-on-year change?
- What is UroGen Pharma TTM net profit?
- What is the all time high TTM net income for UroGen Pharma?
- What is UroGen Pharma TTM net income year-on-year change?
What is UroGen Pharma annual net profit?
The current annual net income of URGN is -$102.24 M
What is the all time high annual net income for UroGen Pharma?
UroGen Pharma all-time high annual net profit is -$1.94 M
What is UroGen Pharma annual net income year-on-year change?
Over the past year, URGN annual net profit has changed by +$7.54 M (+6.87%)
What is UroGen Pharma quarterly net profit?
The current quarterly net income of URGN is -$23.67 M
What is the all time high quarterly net income for UroGen Pharma?
UroGen Pharma all-time high quarterly net profit is $12.92 M
What is UroGen Pharma quarterly net income year-on-year change?
Over the past year, URGN quarterly net profit has changed by -$1.79 M (-8.20%)
What is UroGen Pharma TTM net profit?
The current TTM net income of URGN is -$115.38 M
What is the all time high TTM net income for UroGen Pharma?
UroGen Pharma all-time high TTM net profit is $3.01 M
What is UroGen Pharma TTM net income year-on-year change?
Over the past year, URGN TTM net profit has changed by -$10.28 M (-9.78%)